{
    "meeting_annotations": [
        {
            "speaker": "Peter Dorhout - Iowa State",
            "timestamp": "00:00-00:16",
            "transcript": "improved process through either microfluidic devices or through you know the next generation of multi well capabilities for for doing those high throughput analysis.",
            "speaking duration": 16,
            "nods_others": 4,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "Open Palms",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Brenda Rubenstein (Brown)",
            "timestamp": "00:17-00:40",
            "transcript": "I mean other people might have more experimental experience with this but um, you know I think the the bottleneck is is actually uh creating the the model systems not necessarily the high throughput technology. I I mean I feel like microfluidic people have a handle on that. Um, you know yes there's some drawbacks for 96 well plates or 15 whatever plates. Um, but but that's I I think that's not the barrier here.",
            "speaking duration": 23,
            "nods_others": 2,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Angad Mehta (UIUC)",
            "timestamp": "00:41-01:02",
            "transcript": "Yeah having I'll second that uh especially with viral research the barrier has typically been that you need to either do an in vitro screen or you need to do a viral replicon screen and that's a major limitation uh for actually academic labs pursuing these approaches uh for high throughput screening.",
            "speaking duration": 21,
            "nods_others": 2,
            "smile_self": 14.28,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Brenda Rubenstein (Brown)",
            "timestamp": "01:03-01:03",
            "transcript": "Totally agree.",
            "speaking duration": 1,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Peter Dorhout - Iowa State",
            "timestamp": "01:04-01:32",
            "transcript": "So you you talk about that as as uh, you know a major roadblock to kind of what you would envision for um being necessary to do these high throughput screenings. So is there is there a key technology or a key um advancement in that space that you think is necessary in order to get to um the ideal.",
            "speaking duration": 28,
            "nods_others": 1,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "Open Palms",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Angad Mehta (UIUC)",
            "timestamp": "01:33-01:35",
            "transcript": "Yeah.",
            "speaking duration": 2,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "Yes",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Angad Mehta (UIUC)",
            "timestamp": "01:35-01:46",
            "transcript": "Yeah, I think there's quite a bit of need for developing the right pseudo viral systems for not just receptors but for actually enzymes that are essential for replication of these viruses.",
            "speaking duration": 11,
            "nods_others": 1,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "Pointing",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Wilfred van der Donk UIUC/HHMI",
            "timestamp": "01:47-01:47",
            "transcript": "Yeah.",
            "speaking duration": 1,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "Thumbs up",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Wilfred van der Donk UIUC/HHMI",
            "timestamp": "01:48-02:06",
            "transcript": "I think I think it's a good thing to add. So if we put things on our list that is kind of like a wish list other groups might actually uh really uh look at that and and start discussing, okay, uh this group needs certain technology that isn't there. So I would add it to the summary.",
            "speaking duration": 18,
            "nods_others": 1,
            "smile_self": 22.22,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Angad Mehta (UIUC)",
            "timestamp": "02:07-02:08",
            "transcript": "Uh yes.",
            "speaking duration": 1,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Wilfred van der Donk UIUC/HHMI",
            "timestamp": "02:09-02:17",
            "transcript": "add something that is needed that this group couldn't think of a way to do it but maybe one of the other groups do.",
            "speaking duration": 8,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Erik Procko",
            "timestamp": "02:18-02:48",
            "transcript": "Yeah, I think ways to screen for therapeutics against whether it's it's viruses or other pathogens, um parasitic pathogens which are select agents or need BSL3 containment alternatives so that you can actually do those screens in in a BSL2 lab um under the the working conditions which most most of us have access to rather than than under BL3. That would be very valuable.",
            "speaking duration": 30,
            "nods_others": 1,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Angad Mehta (UIUC)",
            "timestamp": "02:51-03:11",
            "transcript": "Yeah, uh just I briefly mentioned this but our lab actually has been doing for just two types of enzymes uh which are involved in RNA capping system uh for viruses.",
            "speaking duration": 20,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Angad Mehta (UIUC)",
            "timestamp": "03:11-03:20",
            "transcript": "But we don't really have a system for intracellular pathogens for example. There's no system as yet for RNA polymerase and so I think uh uh I I I don't have enough space to write all of this down.",
            "speaking duration": 9,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Angad Mehta (UIUC)",
            "timestamp": "03:20-03:20",
            "transcript": "Do you know if I can go beyond that?",
            "speaking duration": 0,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Wilfred van der Donk UIUC/HHMI",
            "timestamp": "03:21-03:23",
            "transcript": "I'll just add a slide, yeah.",
            "speaking duration": 2,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Peter Dorhout - Iowa State",
            "timestamp": "03:24-03:25",
            "transcript": "make the font smaller.",
            "speaking duration": 1,
            "nods_others": 0,
            "smile_self": 100.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Angad Mehta (UIUC)",
            "timestamp": "03:26-03:27",
            "transcript": "Oh make the font smaller? Okay, let's do that.",
            "speaking duration": 1,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Wilfred van der Donk UIUC/HHMI",
            "timestamp": "03:30-03:34",
            "transcript": "And we can we can get screamed at but we have already done it so.",
            "speaking duration": 4,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Angad Mehta (UIUC)",
            "timestamp": "03:35-03:35",
            "transcript": "Okay.",
            "speaking duration": 0,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Wilfred van der Donk UIUC/HHMI",
            "timestamp": "03:36-03:38",
            "transcript": "So there's nobody here on the call to stop us.",
            "speaking duration": 2,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Angad Mehta (UIUC)",
            "timestamp": "03:39-03:39",
            "transcript": "Okay.",
            "speaking duration": 0,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Wilfred van der Donk UIUC/HHMI",
            "timestamp": "03:56-03:59",
            "transcript": "So they're going to be closing the rooms.",
            "speaking duration": 3,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Peter Dorhout - Iowa State",
            "timestamp": "04:00-04:02",
            "transcript": "So this is this has been a wonderful conversation for.",
            "speaking duration": 2,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "No",
            "screenshare_content": "None"
        },
        {
            "speaker": "Angad Mehta (UIUC)",
            "timestamp": "04:02-04:02",
            "transcript": "Yes.",
            "speaking duration": 0,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "Yes",
            "screenshare_content": "The screen is being shared and displays a Google Docs document titled \"Scaling MZT Meeting Slides\". The document contains a list of key points under the heading \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The list includes items such as using high-throughput platforms for screening small molecule scaffolds and targeted delivery of small molecules/peptides to intracellular pathogens and viruses - nanoparticle based approach."
        },
        {
            "speaker": "Wilfred van der Donk UIUC/HHMI",
            "timestamp": "04:03-04:13",
            "transcript": "can also do uh if if possible to see if we can combine certain points or if there are points that perhaps uh we don't believe are as pressing as others.",
            "speaking duration": 10,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "Yes",
            "screenshare_content": "The screen is being shared and displays a Google Docs document titled \"Scaling MZT Meeting Slides\". The document contains a list of key points under the heading \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The list includes items such as using high-throughput platforms for screening small molecule scaffolds and targeted delivery of small molecules/peptides to intracellular pathogens and viruses - nanoparticle based approach."
        },
        {
            "speaker": "Wilfred van der Donk UIUC/HHMI",
            "timestamp": "04:13-04:20",
            "transcript": "Uh smaller font of course does mean that some people that are on laptops might have a hard time reading things.",
            "speaking duration": 7,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "Yes",
            "screenshare_content": "The screen is being shared and displays a Google Docs document titled \"Scaling MZT Meeting Slides\". The document contains a list of key points under the heading \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The list includes items such as using high-throughput platforms for screening small molecule scaffolds and targeted delivery of small molecules/peptides to intracellular pathogens and viruses - nanoparticle based approach."
        },
        {
            "speaker": "Brenda Rubenstein (Brown)",
            "timestamp": "04:36-04:50",
            "transcript": "And can I also just ask a quick question in the phenotypic platforms that that you've been developing for example on God's um, you know how compatible are they with AI iteration? Uh, so you know you use your platform you identify things you now you got to iterate back.",
            "speaking duration": 14,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "Yes",
            "screenshare_content": "The screen is being shared and displays a Google Docs document titled \"Scaling MZT Meeting Slides\". The document contains a list of key points under the heading \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The list includes items such as using high-throughput platforms for screening small molecule scaffolds and targeted delivery of small molecules/peptides to intracellular pathogens and viruses - nanoparticle based approach."
        },
        {
            "speaker": "Angad Mehta (UIUC)",
            "timestamp": "04:51-05:16",
            "transcript": "Yeah, since some cases they are compatible because the crystal structures of those enzymes are known. In cases where crystal structures are not known they are not compatible. And so uh to directly answer your question for most coronaviruses yes it's definitely compatible.",
            "speaking duration": 25,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "Yes",
            "screenshare_content": "The screen is being shared and displays a Google Docs document titled \"Scaling MZT Meeting Slides\". The document contains a list of key points under the heading \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The list includes items such as using high-throughput platforms for screening small molecule scaffolds and targeted delivery of small molecules/peptides to intracellular pathogens and viruses - nanoparticle based approach."
        },
        {
            "speaker": "Angad Mehta (UIUC)",
            "timestamp": "05:16-05:26",
            "transcript": "For other systems like flaviviruses and filoviruses in some cases the answer is yes in some cases the level of conservation in the enzyme is not high enough.",
            "speaking duration": 10,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "Yes",
            "screenshare_content": "The screen is being shared and displays a Google Docs document titled \"Scaling MZT Meeting Slides\". The document contains a list of key points under the heading \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The list includes items such as using high-throughput platforms for screening small molecule scaffolds and targeted delivery of small molecules/peptides to intracellular pathogens and viruses - nanoparticle based approach."
        },
        {
            "speaker": "Angad Mehta (UIUC)",
            "timestamp": "05:26-05:46",
            "transcript": "Or want to actually predict what the active site might look like if these molecules bind to the active site and so uh it that is limited by the information of the the AI approach essentially is limited by uh the structure of the enzyme.",
            "speaking duration": 20,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "Pointing",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "Yes",
            "screenshare_content": "The screen is being shared and displays a Google Docs document titled \"Scaling MZT Meeting Slides\". The document contains a list of key points under the heading \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The list includes items such as using high-throughput platforms for screening small molecule scaffolds and targeted delivery of small molecules/peptides to intracellular pathogens and viruses - nanoparticle based approach."
        },
        {
            "speaker": "Wilfred van der Donk UIUC/HHMI",
            "timestamp": "05:46-05:52",
            "transcript": "And how how much does alpha fold and Rosetta fold the you know the newest versions thereof.",
            "speaking duration": 6,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "Yes",
            "screenshare_content": "The screen is being shared and displays a Google Docs document titled \"Scaling MZT Meeting Slides\". The document contains a list of key points under the heading \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The list includes items such as using high-throughput platforms for screening small molecule scaffolds and targeted delivery of small molecules/peptides to intracellular pathogens and viruses - nanoparticle based approach."
        },
        {
            "speaker": "Wilfred van der Donk UIUC/HHMI",
            "timestamp": "05:52-06:15",
            "transcript": "Perhaps just a matter of time and they can overcome those those hurdles.",
            "speaking duration": 23,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "Yes",
            "screenshare_content": "The screen is being shared and displays a Google Docs document titled \"Scaling MZT Meeting Slides\". The document contains a list of key points under the heading \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The list includes items such as using high-throughput platforms for screening small molecule scaffolds and targeted delivery of small molecules/peptides to intracellular pathogens and viruses - nanoparticle based approach."
        },
        {
            "speaker": "Angad Mehta (UIUC)",
            "timestamp": "06:15-06:23",
            "transcript": "Uh yes, I think the major problem is uh predicting the ligand binding site uh for essentially the active site.",
            "speaking duration": 8,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "Yes",
            "screenshare_content": "The screen is being shared and displays a Google Docs document titled \"Scaling MZT Meeting Slides\". The document contains a list of key points under the heading \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The list includes items such as using high-throughput platforms for screening small molecule scaffolds and targeted delivery of small molecules/peptides to intracellular pathogens and viruses - nanoparticle based approach."
        },
        {
            "speaker": "Angad Mehta (UIUC)",
            "timestamp": "06:23-06:41",
            "transcript": "Of many of these enzymes uh has been challenging because the RNA threads through those enzymes. And so the active site is typically more complex than simply a nucleotide binding active site.",
            "speaking duration": 18,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "Open Palms",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "Yes",
            "screenshare_content": "The screen is being shared and displays a Google Docs document titled \"Scaling MZT Meeting Slides\". The document contains a list of key points under the heading \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The list includes items such as using high-throughput platforms for screening small molecule scaffolds and targeted delivery of small molecules/peptides to intracellular pathogens and viruses - nanoparticle based approach."
        },
        {
            "speaker": "Angad Mehta (UIUC)",
            "timestamp": "06:41-06:47",
            "transcript": "And so given that they form protein protein complexes which change their confirmations.",
            "speaking duration": 6,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "Yes",
            "screenshare_content": "The screen is being shared and displays a Google Docs document titled \"Scaling MZT Meeting Slides\". The document contains a list of key points under the heading \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The list includes items such as using high-throughput platforms for screening small molecule scaffolds and targeted delivery of small molecules/peptides to intracellular pathogens and viruses - nanoparticle based approach."
        },
        {
            "speaker": "Angad Mehta (UIUC)",
            "timestamp": "06:47-07:00",
            "transcript": "And so these are not really standalone proteins unfortunately which makes it harder to to predict. I can write for for what we do.",
            "speaking duration": 13,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "Yes",
            "screenshare_content": "The screen is being shared and displays a Google Docs document titled \"Scaling MZT Meeting Slides\". The document contains a list of key points under the heading \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The list includes items such as using high-throughput platforms for screening small molecule scaffolds and targeted delivery of small molecules/peptides to intracellular pathogens and viruses - nanoparticle based approach."
        },
        {
            "speaker": "Wilfred van der Donk UIUC/HHMI",
            "timestamp": "07:16-07:23",
            "transcript": "No, I I have nine seconds so I second all of that and a really nice conversation I enjoyed it and hopefully you did too. See you in the in the main room.",
            "speaking duration": 7,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "None",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "Yes",
            "screenshare_content": "The screen is being shared and displays a Google Docs document titled \"Scaling MZT Meeting Slides\". The document contains a list of key points under the heading \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The list includes items such as using high-throughput platforms for screening small molecule scaffolds and targeted delivery of small molecules/peptides to intracellular pathogens and viruses - nanoparticle based approach."
        },
        {
            "speaker": "Peter Dorhout - Iowa State",
            "timestamp": "07:23-08:11",
            "transcript": "Thank you. So this is this has been a wonderful conversation for I think for pretty much everybody in here. This has been your your first experience with a silog I'm assuming. So um the the rest of the the events throughout the course of the you know the next half day, you know the rest today and and then of course going into tomorrow we're going to be very similar in terms of conversation.",
            "speaking duration": 48,
            "nods_others": 0,
            "smile_self": 0.0,
            "smile_other": 0.0,
            "distracted_others": 0,
            "hand_gesture": "Open Palms",
            "interuption": "No",
            "overlap": "No",
            "screenshare": "Yes",
            "screenshare_content": "The screen is being shared and displays a Google Docs document titled \"Scaling MZT Meeting Slides\". The document contains a list of key points under the heading \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The list includes items such as using high-throughput platforms for screening small molecule scaffolds and targeted delivery of small molecules/peptides to intracellular pathogens and viruses - nanoparticle based approach."
        }
    ]
}